Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Bob Swift who wrote (2812)	5/17/1999 11:12:00 PM
From: Don Miller	Respond to of 10280

Check Yahoo #5887 for a first look, Dave may be busy. That is NOT a yahoo club message number. About $2.6/s is the estimate.

To: Bob Swift who wrote (2812)	5/17/1999 11:32:00 PM
From: David Howe	Read Replies (1) \| Respond to of 10280

My earnings model had Nori contributing $220 million of the $1.4 billion in revenue for FY 2003. This is around 15% of the estimated revenue for 2003. Of course the model includes the SG&A costs associated with Nori. These costs would be around $130 million. If you want a worst case scenario, you could completely drop the sales and and the costs from the model and you would end up with a drop in earnings of $90 million. This is around $2.20 per share. The model would then show a remaining $10.44 in earnings for FY 2003. IMO, the outlook is better than this. Dave